Peapack-Gladstone Financial Corp’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,861
Closed -$363K 703
2025
Q1
$363K Sell
15,861
-95,916
-86% -$2.31M 0.01% 526
2024
Q4
$2.83M Sell
111,777
-191,142
-63% -$4.84M 0.04% 286
2024
Q3
$7.55M Buy
302,919
+14,745
+5% +$437K 0.11% 174
2024
Q2
$8.54M Sell
288,174
-17,978
-6% -$499K 0.13% 161
2024
Q1
$9.23M Sell
306,152
-7,316
-2% -$203K 0.14% 153
2023
Q4
$8.97M Buy
313,468
+41,241
+15% +$1.21M 0.15% 151
2023
Q3
$10.1M Buy
272,227
+18,157
+7% +$694K 0.19% 130
2023
Q2
$9.91M Sell
254,070
-5,770
-2% -$226K 0.18% 140
2023
Q1
$9.49M Buy
+259,840
New +$8.2M 0.18% 136

Other funds holding RTO

Peapack-Gladstone Financial Corp's RTO Position: Q2 2025 in Review

Peapack-Gladstone Financial Corp sold out of Rentokil (RTO) in Q2 2025, closing a stake of 15,861 shares — an estimated $363K sold.

Peapack-Gladstone Financial Corp first reported a position in RTO in Q1 2023 and held it in 9 quarters. The position peaked at $10.1M in Q3 2023. 205 funds tracked by Wall St. Rank hold RTO as of Q2 2025.

  • Peapack-Gladstone Financial Corp reported no remaining Rentokil position as of Q2 2025 after selling out during the quarter.
  • Peapack-Gladstone Financial Corp sold 15,861 Rentokil shares in Q2 2025, an estimated $363K.
  • Peapack-Gladstone Financial Corp first reported a position in Rentokil in Q1 2023 and held it in 9 quarters.
  • Peapack-Gladstone Financial Corp's Rentokil position peaked at $10.1M in Q3 2023.
  • 205 funds tracked by Wall St. Rank held Rentokil as of Q2 2025.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2025, filed 14 Aug 2025.